What percentage of patients with Gilbert's syndrome have coronary artery disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gilbert's Syndrome and Coronary Artery Disease Prevalence

Patients with Gilbert's syndrome have a remarkably low prevalence of coronary artery disease at only 2%, compared to 12.1% in the general population of similar age. 1

Evidence from Direct Study

The most relevant research directly addressing this question found that among 50 Gilbert's syndrome patients over age 40 (mean age 49.7 years), the prevalence of ischemic heart disease was 2% (95% CI: 0.05-10.7%), which was significantly lower than the 12.1% prevalence observed in a comparable general population sample of 2,296 individuals (P<0.05). 1

Mechanisms of Cardiovascular Protection

The protective effect against coronary artery disease in Gilbert's syndrome appears multifactorial:

Antioxidant Effects

  • Elevated bilirubin acts as a potent antioxidant, significantly increasing total antioxidant capacity in Gilbert's syndrome patients compared to controls (P<0.05). 1
  • LDL oxidation susceptibility is markedly reduced in Gilbert's syndrome, with significantly lower oxidation levels between 75-120 minutes and prolonged lag-phase compared to healthy controls (P<0.005), which delays the atherosclerotic process. 2

Lipid Profile Benefits

  • HDL cholesterol levels are significantly elevated in Gilbert's syndrome patients compared to controls (P<0.05). 1
  • Total cholesterol and triglyceride concentrations appear decreased in hyperbilirubinemic individuals, accompanied by lower body mass index in well-powered studies. 3
  • However, bilirubin itself accounts for only approximately 34% of the cardioprotective effects according to meta-analysis, with the favorable lipid profile contributing substantially to the remaining protection. 3

Platelet and Inflammatory Markers

  • Mean platelet volume is significantly lower in Gilbert's syndrome patients (7.8±1.0 fl) compared to controls (8.6±1.0 fl, P<0.001), which may reduce thrombotic risk. 4
  • C-reactive protein levels are significantly reduced in Gilbert's syndrome (0.2±0.27 mg/dl) versus controls (0.3±0.38 mg/dl, P=0.037), indicating lower systemic inflammation. 4

Clinical Implications

The 2% prevalence represents an approximately 6-fold reduction in coronary artery disease risk compared to age-matched general population, making Gilbert's syndrome a protective condition rather than a disease requiring treatment. 1 This protection appears most pronounced in males with Gilbert's syndrome, who demonstrate the highest bilirubin levels and lowest mean platelet volumes. 4

The chronic mild hyperbilirubinemia characteristic of Gilbert's syndrome (typically 1-6 mg/dl unconjugated bilirubin) creates a persistently elevated antioxidant state that protects lipoproteins, proteins, and other macromolecules from oxidative damage—the fundamental process underlying atherosclerosis. 1, 3, 5

References

4
Research

The effects of Gilbert's syndrome on the mean platelet volume and other hematological parameters.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013

5
Research

Diagnostic criteria and contributors to Gilbert's syndrome.

Critical reviews in clinical laboratory sciences, 2018

Related Questions

What is the significance of a 1+ bilirubin result on a urine dipstick and how should it be evaluated?
What is the management approach for a 28-year-old female (YOF) with isolated hyperbilirubinemia (elevated total bilirubin)?
What does a bilirubin level of hyperbilirubinemia indicate and how is it managed?
What is the significance of elevated bilirubin with normal cholesterol levels in the context of a family history of gallstones and hemolytic anemia?
What are the implications and management of hyperbilirubinemia with bloating and no abdominal pain?
What are the age‑adjusted normal serum prostate‑specific antigen (PSA) ranges and how should an elevated result be managed?
What is the immediate post‑procedure management for an adult male after incision‑and‑drainage of a left inguinal abscess left unpacked?
What are the age‑adjusted normal prostate‑specific antigen (PSA) levels and the recommended next steps if a man's PSA exceeds the age‑specific cutoff?
In a term neonate delivered by lower‑segment cesarean section with meconium‑stained amniotic fluid who was initially stable but now has feeding intolerance and vomiting after each feed, what are the differential diagnoses and what diagnostic and management steps should be taken?
Why do pelvic floor therapists find biofeedback less effective for patients after colorectal surgery and prefer other modalities such as low‑frequency electrical stimulation, percutaneous tibial nerve stimulation, manual trigger‑point release, or sacral nerve stimulation?
What is the appropriate evaluation and management for a Bartholin's cyst in a sexually active adult woman?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question